ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.4926
-1.47%
Brent Oil
79.22
-1.24%
Bitcoin
103,507.32
0.37%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Clearside Biomedical Inc (CLSD) Cotización

Clearside Biomedical Inc

Clearside Biomedical Inc (CLSD)

NASDAQ
0.9299
0.0049
(0.53%)
Cerrado 20 Enero 3:00PM
Delayed by 15 minutes
0.925
-0.0049
(-0.53%)
Fuera de horario: 6:08PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.925
Postura de Compra
0.925
Postura de Venta
0.95
Volume Operado de la Acción
160,152
0.925 Rango del Día 0.9676
0.801 Rango de 52 semanas 2.12
Capitalización de Mercado [m]
70.155M
Precio Anterior
0.925
Precio de Apertura
0.9316
Hora
1
@
0.965
Última hora de negociación
Volumen financiero
US$ 150,934
Precio Promedio Ponderado
0.942445
Volumen promedio (3 m)
279,804
Acciones en circulación
75,843,504
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.15
Beneficio por acción (BPA)
-0.43
turnover
8.23M
Beneficio neto
-32.49M

Acerca de Clearside Biomedical Inc

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.clearsidebio.com
Sede
Wilmington, Delaware, USA
Fundado
-
Clearside Biomedical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLSD. The last closing price for Clearside Biomedical was US$0.93. Over the last year, Clearside Biomedical shares have traded in a share price range of US$ 0.801 to US$ 2.12.

Clearside Biomedical currently has 75,843,504 shares in issue. The market capitalisation of Clearside Biomedical is US$70.16 million. Clearside Biomedical has a price to earnings ratio (PE ratio) of -2.15.

CLSD Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities

10 Enero 2025
Edgar (US Regulatory)

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

19 Diciembre 2024
GlobeNewswire Inc.

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

- Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroidal Delivery - - Multiple Events at Asia-Pacific Vitreo-Retina Society Congress Highlighting...

25 Noviembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Noviembre 2024
Edgar (US Regulatory)

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Secondary Outcomes - - Positive Topline Results Support Advancing CLS-AX to Phase 3 Targeting a...

12 Noviembre 2024
GlobeNewswire Inc.

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

- Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside’s Suprachoroidal Space...

07 Noviembre 2024
GlobeNewswire Inc.

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

ALPHARETTA, Ga., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

06 Noviembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

04 Noviembre 2024
Edgar (US Regulatory)

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

ALPHARETTA, Ga., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

04 Noviembre 2024
GlobeNewswire Inc.

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

ALPHARETTA, Ga., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

31 Octubre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0459-4.727572355550.97090.99170.90111228320.93822645CS
40.0050.543478260870.921.020.8012903880.93280976CS
12-0.195-17.41071428571.121.160.8012798041.0087589CS
26-0.325-261.251.650.8014937881.18619508CS
52-0.515-35.76388888891.442.120.8013868841.28094767CS
156-1.265-57.76255707762.192.850.6501013186541.47280462CS
260-1.585-63.14741035862.517.730.6501015230792.97803621CS

CLSD - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Clearside Biomedical?
El precio actual de las acciones de Clearside Biomedical es US$ 0.925
¿Cuántas acciones de Clearside Biomedical están en circulación?
Clearside Biomedical tiene 75,843,504 acciones en circulación
¿Cuál es la capitalización de mercado de Clearside Biomedical?
La capitalización de mercado de Clearside Biomedical es USD 70.16M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Clearside Biomedical?
Clearside Biomedical ha negociado en un rango de US$ 0.801 a US$ 2.12 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Clearside Biomedical?
El ratio precio/beneficio de Clearside Biomedical es -2.15
¿Cuál es el ratio de efectivo a ventas de Clearside Biomedical?
El ratio de efectivo a ventas de Clearside Biomedical es 8.48
¿Cuál es la moneda de reporte de Clearside Biomedical?
Clearside Biomedical presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Clearside Biomedical?
El último ingresos anual de Clearside Biomedical es USD 8.23M
¿Cuál es el último beneficio anual de Clearside Biomedical?
El último beneficio anual de Clearside Biomedical es USD -32.49M
¿Cuál es la dirección registrada de Clearside Biomedical?
La dirección registrada de Clearside Biomedical es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Clearside Biomedical?
La dirección del sitio web de Clearside Biomedical es www.clearsidebio.com
¿En qué sector industrial opera Clearside Biomedical?
Clearside Biomedical opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

CLSD Discussion

Ver más
georgie18 georgie18 3 semanas hace
CLSD...95...🥳...Setting up for $1.20 Break...imo...we shall see... https://schrts.co/nhFdXepw

CLSD...$1.45...🥳...ALPHARETTA, Ga., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that the ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) for the treatment of neovascular age-related macular degeneration (wet AMD) achieved both its primary and secondary outcomes. In participants who received CLS-AX delivered suprachoroidally, best corrected visual acuity (BCVA) and ocular anatomy (central subfield thickness) were stable up to 6 months compared to participants who received aflibercept. In addition, CLS-AX demonstrated a well-tolerated safety profile to Week 36 inclusive of mandatory re-dosing of CLS-AX at Week 24.
👍️0
Invest-in-America Invest-in-America 3 meses hace
CLSD: Nice news for sure, but heavy FLOAT of 63-million..
👍️0
Awl416 Awl416 3 meses hace
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
👍️0
BBANBOB BBANBOB 3 meses hace
CLSD 1.52
👍️0
BBANBOB BBANBOB 5 meses hace
CLSD under 1$ @ .9355
👍️0
Monksdream Monksdream 5 meses hace
CLSD under $2
👍️0
Monksdream Monksdream 7 meses hace
CLSD under $2
👍️0
Monksdream Monksdream 9 meses hace
CLSD under $2
👍️0
BBANBOB BBANBOB 10 meses hace
I'll suggest now that the GAP FILLED yesterday and it takes news 2-3 days to be digested, tomorrow we hopefully head back to the 2$ area, just my WAG bwthdik
👍️0
BBANBOB BBANBOB 10 meses hace
WHO KNOWS PARD WHO KNOWS
👍️ 1
BBANBOB BBANBOB 10 meses hace
.
👍️0
jhdf51 jhdf51 10 meses hace
Great..well maybe just maybe we are finally on our way albeit perhaps a bumpy ride...

JHD
👍️0
BBANBOB BBANBOB 10 meses hace
JHD

NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2

Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
👍️0
jhdf51 jhdf51 10 meses hace
Same ol same ol
👍️0
BBANBOB BBANBOB 10 meses hace
WE BOTH HAVE THE SAME PROBLEM

DNDN been there done that and not again
👍️ 1
BBANBOB BBANBOB 10 meses hace
.53 cent loss versus .55 loss last yr
👍️0
jhdf51 jhdf51 10 meses hace
Yep..I was thinking of getting out but same...
👍️0
BBANBOB BBANBOB 10 meses hace
Not REAL THRILLED with the earnings to be released AH's that is normally indicative of bad numbers, so looks like the 2.12 was a head fake for some to get out
I came close to selling 50% yesterday and get back in when it closes the gap @ 1.54,,,,,,, but just couldn't find the CAJONES to do it..........OH WELL NO BALLS NO BLACK CHIPS
👍️0
BBANBOB BBANBOB 10 meses hace
Appears they are playing this real hard to get shares all the way to 1.81 from 2.12
👍️0
BBANBOB BBANBOB 10 meses hace
1.87 NEW annual high and HOD. 3 trade days ago we did 3 mill shares and VOL proceeds PPS

MY WAG is this is over 2$ by weeks end.

AND NO not pumping this since I have held it for over 2 yrs NOV of 2022 and @ $4.86 finally got my avg to $2.00
👍️0
Monksdream Monksdream 10 meses hace
CLSD 10Q due March 12
👍️0
Monksdream Monksdream 10 meses hace
CLSD new 52 week hi
👍️0
glenn1919 glenn1919 10 meses hace
CLSD....................................................https://stockcharts.com/h-sc/ui?s=CLSD&p=W&b=5&g=0&id=p86431144783
👍️0
BBANBOB BBANBOB 10 meses hace
And on VERY GOOD VOL, me thinks something is up
👍️0
Monksdream Monksdream 11 meses hace
CLSD new 52 week high
👍️0
Monksdream Monksdream 11 meses hace
CLSD under $2
👍️0
BBANBOB BBANBOB 1 año hace
OOOOOOOOOOOOOPS $1.47
👍️0
BBANBOB BBANBOB 1 año hace
OPPPPPPPPPPPPPPS .6951
👍️0
BBANBOB BBANBOB 1 año hace
APPEARS we just made a new one too DAMN @ .70

I'm hoping they are tanking it in front of good earning to pick it up I KNOWWWWWWWWWWWWWWWWWWWWWWWWWWWW
👍️0
Monksdream Monksdream 1 año hace
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 año hace
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 año hace
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 año hace
CLSD new 52 week low
👍️0
heyitsmeagain heyitsmeagain 2 años hace
Here we go
👍️0
heyitsmeagain heyitsmeagain 2 años hace
Loaded for this runner. Wish I had more loot.
👍️0
BBANBOB BBANBOB 3 años hace
Hard to Borrow is back on CLSD today
👍️0
BBANBOB BBANBOB 3 años hace
FYI

THE HARD TO BORROW classification(at Schwab) just went POOF GHONDI as of today on CLSD and at the same time its is up 3.81%

HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
👍️0
BBANBOB BBANBOB 3 años hace
Well so far so good !!!!!!!!!!!!!!!!!! Let's say for grins $3 on Fri
👍️0
BBANBOB BBANBOB 3 años hace
Well well let's give this news 2-3 days to digest and see where it is by weeks end.

Also if if if this is gonna take off as I believe, the first part of the week MIGHT JUST SCARE THE WEAK here.

If you're faint at heart or can't handle pressure, one might want to JUST NOT LOOK for the next few days
👍️0
jhdf51 jhdf51 3 años hace
Now that would be perfect. I’d hire me a farm hand, or two, or three! Lol

JHD
👍️0
BBANBOB BBANBOB 3 años hace
Again

Earnings was a beat and they were .31 for the LAST quarter PER SHARE, do that X's a whole yr and then X's a multiple of 10-12 and there ya have it.

NOW Since this appears to be JUST the start of licensing, who knows how many more licenses will be entered into in the next year.

MY PPS prediction would be along the lines of $27-$35 in the next 12 months WAG and IMHO
👍️0
jhdf51 jhdf51 3 años hace
Yes I agree. Definitely could be. Dang Price targets are never exact anyway.
👍️0
BBANBOB BBANBOB 3 años hace
I'll take $9 for this year, but still say it will be more.
👍️0
jhdf51 jhdf51 3 años hace
I see $9. $18 was last year.

https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nasdaq-clsd-a-buy-or-sell-right-now-2022-03-2/amp/
👍️0
BBANBOB BBANBOB 3 años hace
But all companies good or bad always have HEDGE FUNDS that short their stock, THUS the meaning of HEDGE, being on both sides of the trade, much like a BOOKIE taking sports bets will take EITHER SIDE of a bet.

BUT unlike a bookie that takes your bet and at half time IS WAY UPSIDE down on the bet he made with you, HE DOES NOT HAVE THE OPPORTUNITY to CHANGE his bet, SHORTS DO at any given time

THUNK ABOUT IT BOYZZZZZZZZZZZ
👍️0
BBANBOB BBANBOB 3 años hace
SHORTS

Again as I did last week, I would serious suggest that you close even the few shorts you have still open here, as it might get REAL NASTY if ya don't, JUST SAYING
👍️0
BBANBOB BBANBOB 3 años hace
Having NOT been able to take part in PICKING UP SHARES last week, I just got back to even as of today at one point. IF IF IF it closes over 2.39 today, then FINALLY again I am BACK in the black.
👍️0
BBANBOB BBANBOB 3 años hace
Well YET AGAIN it seems my 3 day rule on it taking 3 days for news to be fully digested before a stock rises,has yet again proven itself true..
👍️0
BBANBOB BBANBOB 3 años hace
CRUDEOIL

I have always suggested on these boards that, ""IT TAKE 3 days for news to be really digested before ya see real up swings, HMMMMMMMM
👍️0
BBANBOB BBANBOB 3 años hace
OH I agree 100% and suggested that ALL for the last months JUST SIT ON THEIR HANDS or add.....

Me aint got no dry powder or I would have last week and large
👍️0

Su Consulta Reciente

NASDAQ
CLSD
Clearside Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados